Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy

Nicotine and Tobacco Research

Volumn 10, Issue 4, 2008, Pages 731-736

  Shuter, Jonathan ^a   Bernstein, Steven ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOPINAVIR PLUS RITONAVIR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DRUG ABUSE; EDUCATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PATIENT COMPLIANCE; PATIENT INFORMATION; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT REFUSAL;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; COHORT STUDIES; COMORBIDITY; FEMALE; HIV INFECTIONS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; SELF EFFICACY; SMOKING; SOCIAL SUPPORT; TOBACCO USE DISORDER; TREATMENT REFUSAL; UNITED STATES;

EID: 42449156793     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200801908190     Document Type: Article

References (35)

1. Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., Buono, D., Eckholdt, H., Howard, A. A. and Schoenbaum, E. E. (2001) Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, pp. 1417-1423.
2. Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A. and Schoenbaum, E. E. (2002) Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, pp. 377-381.
3. Bangsberg, D. R. (2006) Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases, 43, pp. 939-941.
4. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A. and Moss, A. (2000) Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, pp. 357-366.
5. Berg, K. M., Demas, P. A., Howard, A. A., Schoenbaum, E. E., Gourevitch, M. N. and Arnsten, J. H. (2004) Gender differences in factors associated with adherence to antiretroviral therapy. Journal of General Internal Medicine, 19, pp. 1111-1117.
6. Burkhalter, J. E., Springer, C. M., Chhabra, R., Ostroff, J. S. and Rapkin, B. D. (2005) Tobacco use and readiness to quit in low-income HIV-infected persons. Nicotine & Tobacco Research, 7, pp. 511-522.
7. Burns, D. N., Hillman, D., Neaton, J. D., Sherer, R., Mitchell, T., Capps, L., Vallier, W. G., Thurnherr, M. D. and Gordin, F. M. (1996) Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, pp. 374-383.
8. Camenga, D. R., Klein, J. D. and Roy, J. (2006) Changing risk profile of the American adolescent smoker: Implications for prevention programs and tobacco interventions. Journal of Adolescent Health, 39, p. 120.e1.
9. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group (2003) Combination antiretroviral therapy and the risk of myocardial infarction. The New England Journal of Medicine, 349, pp. 1993-2003.
10. Davidson, H., Schluger, N. W., Feldman, P. H., Valentine, D. P., Telzak, E. E. and Laufer, F. N. (2000) The effects of increasing incentives on adherence to tuberculosis directly observed therapy. International Journal of Tuberculosis and Lung Disease, 4, pp. 860-865.
11. Defino, M., Clark, J., Mogyoros, D. and Shuter, J. (2004) Predictors of virologic success in patients completing a structured antiretroviral adherence program. Journal of the Association of Nurses in AIDS Care, 15, pp. 60-67.
12. Feldman, J. G., Minkoff, H., Schneider, M. F., Gange, S. J., Cohen, M., Watts, D. H., Gandhi, M., Mocharnuk, R. S. and Anastos, K. (2006) Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the Women's Interagency HIV Study. American Journal of Public Health, 96, pp. 1060-1065.
13. Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J. and Levy, R. (2002) Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education and Counseling, 46, pp. 93-108.
14. French, T., Tesoriero, J., Weiss, L., Waters, M., Woolston, B. and Agins, B. (2006) The New York State Treatment Adherence Initiative: Assessment and validation of measures of adherence and psychological distress.
15. French, T., Tesoriero, J., Weiss, L., Waters, M., Woolston, B. and Agins, B. (2006) The New York State Treatment Adherence Initiative: Correlates and predictors of non-adherence.
16. Galai, N., Park, L. P., Wesch, J., Visscher, B., Riddler, S. and Margolick, J. B. (1997) Effect of smoking on the clinical progression of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 14, pp. 451-458.
17. Granger, B. B., Swedberg, K., Ekman, I., Granger, C. B., Olofsson, B., McMurray, J. J., Yusuf, S., Michelson, E. and Pfeffer, M. (2005) Adherence to candesartan and placebo and outcomes in congestive heart failure in the CHARM programme: Double-blind, randomized, controlled clinical trial. Lancet, 366, pp. 2005-2011.
18. Gross, R., Bilker, W. B., Friedman, H. M. and Strom, B. L. (2001) Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS, 15, pp. 2109-2117.
19. Hessol, N. A., Anastos, K., Levine, A. M., Ameli, N., Cohen, M., Young, M., Augenbraun, M., Miotti, P. and Gange, S. (2000) Factors associated with incident self-reported AIDS among women enrolled in the Women's Interagency HIV Study (WIHS). AIDS Research and Human Retroviruses, 16, pp. 1105-1111.
20. Howard, A. A., Arnsten, J. H., Lo, Y., Vlahov, D., Rich, J. D., Schuman, P., Stone, V. E., Smith, D. K. and Shoenbaum, E. E. (2002) A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS, 16, pp. 2175-2182.
21. Kalichman, S. C., Catz, S. and Ramachandran, B. (1999) Barriers to HIV/ AIDS treatment adherence among African-American adults with disadvantaged education. Journal of the National Medical Association, 91, pp. 439-446.
22. Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., Christian, J., Maldonado, T., Duran, D., Kaplan, A. H. and Wenger, N. S. (2001) A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, pp. 968-977.
23. Lucas, G. M. (2005) Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: A tangled web is woven. Journal of Antimicrobial Chemotherapy, 55, pp. 413-416.
24. Mamary, E. M., Bahrs, D. and Martinez, S. (2002) Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care and STDs, 16, pp. 39-42.
25. Moorman, A. C., Holmberg, S. D., Marlowe, S. I., Von Bargen, J. C., Yangco, B. G., Palella, F. J., Ward, D. J., Loveless, M. O., Furher, J., Joseph, P., Alexander, W. A. and Aschman, D. J. (1999) Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: The HIV Outpatient Study (HOPS). Annals of Epidemiology, 9, pp. 349-357.
26. Odum, A. L., Madden, G. J. and Bickel, W. K. (2002) Discounting of delayed health gains and losses by current, never- and ex-smokers of cigarettes. Nicotine & Tobacco Research, 4, pp. 295-303.
27. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M. and Singh, N. (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, pp. 21-30.
28. Purkayastha, T., Wasi, F. and Shuter, J. (2005) Factors associated with sustained virologic suppression in patients receiving antiretroviral therapy in an urban HIV care clinic. AIDS Patient Care and STDs, 19, pp. 785-793.
29. Rawlings, M. K., Thompson, M. A., Farthing, C. F., Brown, L. S., Racine, J., Scott, R. C., Crawford, K. H., Goodwin, S. D., Tolson, J. M., Williams, V. C. and Shaefer, M. S. (2003) Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/ zidovudine/abacavir regimen in underrepresented HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 34, pp. 174-183.
30. Schnoll, R. A., Malstrom, M., James, C., Rothman, R. L., Miller, S. M., Ridge, J. A., Movsas, B., Unger, M., Langer, C. and Goldberg, M. (2002) Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Education and Counseling, 46, pp. 137-145.
31. Shuter, J., Sarlo, J. A., Kanmaz, T. J., Rode, R. A. and Zingman, B. S. (2007) HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates below 95%. Journal of Acquired Immune Deficiency Syndromes, 45, pp. 4-8.
32. Turner, J., Page-Shafer, K., Chin, D. P., Osmond, D., Mossar, M., Markstein, L., Huitsing, J., Barnes, S., Clemente, V. and Chesney, M. (2001) Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care and STDs, 15, pp. 615-624.
33. Vidrine, D. J., Arduino, R. C., Lazev, A. B. and Gritz, E. R. (2006) A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS, 20, pp. 253-260.
34. Wewers, M. E., Neidig, J. L. and Kihm, K. E. (2000) The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. Journal of the Association of Nurses in AIDS Care, 11, pp. 37-44.
35. Zaghloul, S. S., Cunliffe, W. J. and Goodfield, M. J. D. (2005) Objective assessment of compliance with treatments in acne. British Journal of Dermatology, 152, pp. 1015-1021.